Cargando…
Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
Coronavirus disease-19 (COVID-19), a devastating respiratory illness caused by SARS-associated coronavirus-2 (SARS-CoV-2), has already affected over 64 million people and caused 1.48 million deaths, just 12 months from the first diagnosis. COVID-19 patients develop serious complications, including s...
Autores principales: | Thimmulappa, Rajesh K., Mudnakudu-Nagaraju, Kiran Kumar, Shivamallu, Chandan, Subramaniam, K.J.Thirumalai, Radhakrishnan, Arun, Bhojraj, Suresh, Kuppusamy, Gowthamarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899028/ https://www.ncbi.nlm.nih.gov/pubmed/33655086 http://dx.doi.org/10.1016/j.heliyon.2021.e06350 |
Ejemplares similares
-
Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
por: Manjunath, Souparnika H., et al.
Publicado: (2022) -
Olfactory drug delivery of artemether-curcumin combination for management of cerebral malaria
por: Jain, Kunal, et al.
Publicado: (2012) -
Modulation of cerebral malaria by curcumin as an adjunctive therapy
por: Jain, Kunal, et al.
Publicado: (2013) -
Antiviral and Immunomodulatory Drugs
por: Sykes, Jane E., et al.
Publicado: (2014) -
Design and development of hydrogel nanoparticles for mercaptopurine
por: Senthil, V., et al.
Publicado: (2010)